Very true. but Dr. J also said we wont be commericalizing it--ie we will be sold. But to Merck, image doubling your revenue, maybe quadrupling your profits, on a mAb produced by Samsung for probably a few dollars a dose with CMC already established. How much sales staff would anyone need for a drug like this. Might make Ozempic and Zepbound look like small potatoes.